Table of Contents
1.1 List of Tables 14
1.2 List of Figures 26
2 Introduction 27
2.1 Inborn Gene or Chromosome Alterations Overview 27
3 Products under Development 28
3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 28
3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory 29
3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 30
3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 31
3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials 32
4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies 33
4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 33
4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 39
5 Inborn Gene or Chromosome Alterations Companies and Product Overview 47
6 Inborn Gene or Chromosome Alterations- Recent Developments 282
7 Appendix 484
Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development 28
Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory 29
Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path 30
Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date 31
Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials 32
Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development 33
Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development 39
Table 8: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 9: Molecular Diagnostic Test - Bipolar Disorder - Product Status 47
Table 10: Molecular Diagnostic Test - Bipolar Disorder - Product Description 47
Table 11: Molecular Diagnostic Test - Depression - Product Status 48
Table 12: Molecular Diagnostic Test - Depression - Product Description 48
Table 13: Molecular Diagnostic Test - Parkinson's Disease - Product Status 48
Table 14: Molecular Diagnostic Test - Parkinson's Disease - Product Description 49
Table 15: Molecular Diagnostic Test - Schizophrenia - Product Status 49
Table 16: Molecular Diagnostic Test - Schizophrenia - Product Description 49
Table 17: Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 18: Diagnostic Test - Type 2 Diabetes - Product Status 50
Table 19: Diagnostic Test - Type 2 Diabetes - Product Description 50
Table 20: Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 51
Table 21: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Status 51
Table 22: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Description 51
Table 23: Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 24: Sensigene Trisomy 21 Laboratory Developed Test - Product Status 52
Table 25: Sensigene Trisomy 21 Laboratory Developed Test - Product Description 52
Table 26: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 27: SmartPanel - Product Status 53
Table 28: SmartPanel - Product Description 53
Table 29: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 30: Diagnostic Test - IFN-Beta Resistance - Product Status 54
Table 31: Diagnostic Test - IFN-Beta Resistance - Product Description 54
Table 32: Amity University Pipeline Products & Ongoing Clinical Trials Overview 55
Table 33: Prenatal Screening Kit - Product Status 55
Table 34: Prenatal Screening Kit - Product Description 55
Table 35: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
Table 36: PDx Pre-Symptomatic Test - Product Status 56
Table 37: PDx Pre-Symptomatic Test - Product Description 56
Table 38: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 39: Diagnostic Test - Neurodegenerative Disorders - Product Status 57
Table 40: Diagnostic Test - Neurodegenerative Disorders - Product Description 57
Table 41: Signature CF Expand - Product Status 58
Table 42: Signature CF Expand - Product Description 58
Table 43: Augusta University Pipeline Products & Ongoing Clinical Trials Overview 59
Table 44: SUMO Gene Test - Type 1 Diabetes - Product Status 59
Table 45: SUMO Gene Test - Type 1 Diabetes - Product Description 59
Table 46: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 47: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status 60
Table 48: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description 60
Table 49: DNA Guided Diagnostic Test - Diabetes - Product Status 61
Table 50: DNA Guided Diagnostic Test - Diabetes - Product Description 61
Table 51: DNA Guided Diagnostic Test - Obesity - Product Status 61
Table 52: DNA Guided Diagnostic Test - Obesity - Product Description 62
Table 53: INFINITI Factor II-V And MTHFR Assay - Product Status 62
Table 54: INFINITI Factor II-V And MTHFR Assay - Product Description 62
Table 55: INFINITI FMF Assay - Product Status 63
Table 56: INFINITI FMF Assay - Product Description 63
Table 57: INFINITI MTHFR Assay - Product Status 63
Table 58: INFINITI MTHFR Assay - Product Description 64
List of Figures
Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development 28
Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory 29
Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path 30
Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date 31
Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials 32
【免責事項】
https://www.marketreport.jp/reports-disclaimer